R 1496
Latest Information Update: 05 Jul 2006
At a glance
- Originator Roche
- Class Obesity therapies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 05 Jul 2006 No development reported - Preclinical for Obesity in Switzerland (unspecified route)
- 19 Apr 2004 Preclinical trials in Obesity in Switzerland (unspecified route)